Institute of Pathology

An Innovative Arteriovenous (AV) Loop Breast Cancer Model Tailored for Cancer Research (2022) An R, Strissel P, Al-Abboodi M, Robering JW, Reakasame S, Eckstein M, Peddi A, et al. Journal article Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naive patients with non-small cell lung cancer (2022) Zhang R, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, Schmidkonz C, Atzinger A, Kuwert T, et al. Journal article Editorial: Epithelial to Mesenchymal Plasticity in Colorectal Cancer (2022) Bocci F, Schneider-Stock R, Banerjee S Journal article Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women (2022) Hampl M, Hesselink AT, Meijer CJLM, Denecke A, Einhorn I, Reinecke-Luethge A, Geppert CI, et al. Journal article Targeted deletion of Interleukin-3 results in asthma exacerbations (2022) Kölle J, Zimmermann T, Kiefer A, Rieker R, Xepapadaki P, Zundler S, Papadopoulos NG, Finotto S Journal article Discovery of a novel soluble Neuropilin-2 isoform with antiangiogenic and antitumorigenic activity (2022) Mayr T, Dix PL, Hasheminasab SM, Hampel C, Sylvester M, Schneberger N, Foerster S, et al. Conference contribution Biomarkers of precancerous colorectal cancer stages identified by transcriptome profiling (2022) Siskova A, Vymetalkova V, Vodicka P, Ferrero G, Naccarati A, Hampel C, Schneider-Stock R Conference contribution A large-scale MicroRNA functional high-throughput screening identifies members of the MiR-515 family as potent inducers of human IPSC-cardiomyocyte proliferation (2022) Gong Y, Renikunta H, Lazarow K, Giral H, Kratzer A, Opitz L, Haghikia A, et al. Conference contribution A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity (2022) Vargas JG, Wagner J, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, et al. Journal article Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. (2022) Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, et al. Conference contribution